Efficacy/Safety of Antibiotic Steroid Combination in Prevention of Post Operative Inflammation in LASIK Surgery

Sponsor
Federal University of São Paulo (Other)
Overall Status
Completed
CT.gov ID
NCT00330824
Collaborator
(none)
64
1
2
8
8

Study Details

Study Description

Brief Summary

Efficacy/Safety of antibiotic steroid combination compared with individual administration in inflammation Post-LASIK

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

antibiotic/steroid combination compared to individuals components 15 days of treatment

Study Design

Study Type:
Interventional
Actual Enrollment :
64 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Prevention
Official Title:
Efficacy of Antibiotic Steroid Combination Compared With Individual Administration in Prevention of Post Operative Inflammation in Patients Having LASIK Surgery
Study Start Date :
Apr 1, 2006
Actual Primary Completion Date :
Sep 1, 2006
Actual Study Completion Date :
Dec 1, 2006

Arms and Interventions

Arm Intervention/Treatment
Experimental: antibiotic steroid (single vial)

efficacy of antibiotic steroid combination compared with individual administration in prevention of postoperative inflammation in patients having LASIK surgery

Drug: antibiotic/steroid combination
1gtt, 4x/d, 15 days
Other Names:
  • moxifloxacin/dexamethasone
  • Active Comparator: antibiotic / steroid (2 vials)

    efficacy of antibiotic steroid combination compared with individual administration in prevention of postoperative inflammation in patients having LASIK surgery

    Drug: moxifloxacin/dexamethasone
    1gtt, 4x/days, 15 days
    Other Names:
  • moxifloxacin / dexamethasone
  • Outcome Measures

    Primary Outcome Measures

    1. day 15 evaluation of anterior chamber [15 days pos-op]

    Secondary Outcome Measures

    1. day 15 evaluation of ocular pain, physician´s follow-up impression of inflammatory reaction score [15 days pos-op]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patients having LASIK surgery;

    • men or women of any race, between 18 and 50 years old, presenting up to 8 degrees of myopia or up to 4 degrees of hypermetropia, or up to 3 degrees of astigmatism, without any other associated ocular problems

    Exclusion Criteria:
    • Uncontrolled glaucoma or intraocular hypertension;

    • Use of any ocular anti-infectious drugs or any topical or systemic ocular NSAIDs during the study but study drugs;

    • A history of chronic or recurrent ocular inflammatory disease;

    • Uncontrolled diabetes mellitus and diabetic retinopathy ;

    • Patients with sight in a single eye;

    • Iris atrophy in the eye to be operated;

    • Pregnant or lactating women, or women of childbearing potential who are not using proper birth-control methods;

    • Known or suspected allergy or hypersensitivity to any component of study medication;

    • A history or any other evidence of severe systemic disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Dept. of Ophthalmology - Rua Botucatu 824 São paulo SP Brazil 04023-062

    Sponsors and Collaborators

    • Federal University of São Paulo

    Investigators

    • Principal Investigator: Rubens Belfort Jr, MD, PhD, Federal University of São Paulo

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00330824
    Other Study ID Numbers:
    • BRA-05-02
    First Posted:
    May 29, 2006
    Last Update Posted:
    Aug 7, 2009
    Last Verified:
    Aug 1, 2009

    Study Results

    No Results Posted as of Aug 7, 2009